• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解皮肤红斑狼疮患者的疾病负担和未满足的需求:一项定性研究。

Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.

作者信息

Ogunsanya M E, Brown C M, Lin D, Imarhia F, Maxey C, Chong B F

机构信息

College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

College of Pharmacy, The University of Texas at Austin, Texas.

出版信息

Int J Womens Dermatol. 2018 Apr 13;4(3):152-158. doi: 10.1016/j.ijwd.2018.01.002. eCollection 2018 Sep.

DOI:10.1016/j.ijwd.2018.01.002
PMID:30175217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6116830/
Abstract

BACKGROUND

Cutaneous lupus erythematosus (CLE) is a rare dermatologic autoimmune disease marked by photosensitive lesions that can vary in appearance depending on the subtype. The extent to which CLE affects a patient's quality of life (QoL) has not been fully characterized. Focus groups were conducted to explore patients' perspectives of how CLE has affected their lives and to understand the unmet needs in regards to CLE treatment and care.

METHODS

This qualitative study involved three focus groups with a total of 19 patients with CLE. A moderator guide containing open-ended questions was used to assess how CLE affects overall QoL. The focus groups were audio-recorded with notetaking. Data were content-analyzed to identify emergent themes.

RESULTS

Four themes emerged as important to patients with CLE: disease sequelae, social interactions, functioning, and unmet needs. Most patients reported decreased QoL due to signs and symptoms such as dyspigmentation and scarring. Having CLE negatively affected patients' mental health and personal relationships and led to negative coping strategies, such as recreational drug use. Issues related to body image were also elicited by patients. Patients cited unmet needs including lack of treatments to improve chronic skin lesions of CLE and inadequate patient education on living with CLE.

CONCLUSIONS

Providers can look for signs of QoL impairment in patients with CLE by asking questions related to body image, mental health, social isolation, and coping mechanisms. Future QoL measures can include the effect of CLE-specific attributes such as scarring and dyspigmentation to empower patients' voices in determining therapeutic efficacy in future clinical trials. Findings from our study have added a new understanding of daily experiences that were elicited directly from patients with CLE.

摘要

背景

皮肤型红斑狼疮(CLE)是一种罕见的皮肤自身免疫性疾病,其特征为光敏性皮损,外观因亚型而异。CLE对患者生活质量(QoL)的影响程度尚未完全明确。开展焦点小组讨论以探讨患者对CLE如何影响其生活的看法,并了解CLE治疗和护理方面未满足的需求。

方法

这项定性研究包括三个焦点小组,共有19名CLE患者参与。使用包含开放式问题的主持人指南来评估CLE如何影响总体生活质量。焦点小组讨论进行了录音并做了笔记。对数据进行内容分析以确定新出现的主题。

结果

对于CLE患者而言,有四个主题显得很重要:疾病后遗症、社交互动、功能状况和未满足的需求。大多数患者报告称,由于色素沉着和瘢痕等体征和症状,生活质量下降。患有CLE对患者的心理健康和人际关系产生负面影响,并导致消极的应对策略,如使用消遣性药物。患者还提到了与身体形象有关的问题。患者指出了未满足的需求,包括缺乏改善CLE慢性皮肤病变的治疗方法以及关于CLE患者生活的患者教育不足。

结论

医疗服务提供者可以通过询问与身体形象、心理健康、社会隔离和应对机制相关的问题,来寻找CLE患者生活质量受损的迹象。未来的生活质量衡量标准可以包括CLE特定属性(如瘢痕和色素沉着)的影响,以便在未来的临床试验中增强患者在确定治疗效果方面的话语权。我们研究的结果为直接来自CLE患者的日常经历增添了新的认识。

相似文献

1
Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.了解皮肤红斑狼疮患者的疾病负担和未满足的需求:一项定性研究。
Int J Womens Dermatol. 2018 Apr 13;4(3):152-158. doi: 10.1016/j.ijwd.2018.01.002. eCollection 2018 Sep.
2
Exploring the Perspectives of Patients Living With Lupus: Retrospective Social Listening Study.探索狼疮患者的观点:回顾性社会倾听研究
JMIR Form Res. 2024 Feb 2;8:e52768. doi: 10.2196/52768.
3
Cutaneous lupus concerns from the patient perspective: a qualitative study.从患者角度看皮肤狼疮:一项定性研究。
Lupus Sci Med. 2021 Aug;8(1). doi: 10.1136/lupus-2020-000444.
4
Treatments for disease damage in cutaneous lupus erythematosus: A narrative review.皮肤红斑狼疮疾病损害的治疗:叙述性综述。
Dermatol Ther. 2021 Sep;34(5):e15034. doi: 10.1111/dth.15034. Epub 2021 Jun 28.
5
A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.皮肤红斑狼疮患者报告结局的系统评价。
Br J Dermatol. 2017 Jan;176(1):52-61. doi: 10.1111/bjd.14868. Epub 2016 Dec 7.
6
The Burden of Living With Cutaneous Lupus Erythematosus.皮肤红斑狼疮的生活负担
Front Med (Lausanne). 2022 Aug 8;9:897987. doi: 10.3389/fmed.2022.897987. eCollection 2022.
7
Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus.评估皮肤红斑狼疮患者疾病特异性生活质量的测量工具的验证和可靠性。
Br J Dermatol. 2019 Jun;180(6):1430-1437. doi: 10.1111/bjd.17636. Epub 2019 Apr 7.
8
Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.采用修订版 Wilson 和 Cleary 模型评估红斑狼疮患者生活质量的相关因素。
Lupus. 2020 Nov;29(13):1691-1703. doi: 10.1177/0961203320951842. Epub 2020 Sep 3.
9
Cutaneous lupus erythematosus: An update.皮肤型红斑狼疮:最新进展。
Indian Dermatol Online J. 2014 Jan;5(1):7-13. doi: 10.4103/2229-5178.126020.
10
Severity Scores for Cutaneous Lupus Erythematosus.红斑狼疮皮肤损伤严重程度评分。
J Invest Dermatol. 2024 Nov;144(11):2354-2363. doi: 10.1016/j.jid.2024.07.032. Epub 2024 Sep 14.

引用本文的文献

1
Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultations.评估罕见病患者及其照护者未满足的健康相关需求的标准:快速文献综述和利益相关者咨询
Orphanet J Rare Dis. 2025 Jul 1;20(1):321. doi: 10.1186/s13023-025-03838-6.
2
Outcome Measures in Dystrophic Calcinosis Cutis: A Systematic Review.营养不良性皮肤钙化症的结局指标:一项系统评价
JID Innov. 2025 Apr 3;5(4):100368. doi: 10.1016/j.xjidi.2025.100368. eCollection 2025 Jul.
3
Dynamic changes of amplitude of low-frequency in systemic lupus erythematosus patients with cognitive impairment.系统性红斑狼疮认知功能障碍患者低频振幅的动态变化
Front Neurosci. 2022 Aug 23;16:929383. doi: 10.3389/fnins.2022.929383. eCollection 2022.
4
The Burden of Living With Cutaneous Lupus Erythematosus.皮肤红斑狼疮的生活负担
Front Med (Lausanne). 2022 Aug 8;9:897987. doi: 10.3389/fmed.2022.897987. eCollection 2022.
5
Depression, stigma and social isolation: the psychosocial trifecta of primary chronic cutaneous lupus erythematosus, a cross-sectional and path analysis.抑郁、污名化和社会孤立:原发性慢性皮肤红斑狼疮的心理社会三联征,一项横断面和路径分析。
Lupus Sci Med. 2022 Aug;9(1). doi: 10.1136/lupus-2022-000697.
6
Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need.制定一个用于红斑狼疮性皮肤病的工作核心结局集:满足一个急迫未满足需求的实用方法。
Lupus Sci Med. 2021 Dec;8(1). doi: 10.1136/lupus-2021-000529.
7
Cutaneous lupus concerns from the patient perspective: a qualitative study.从患者角度看皮肤狼疮:一项定性研究。
Lupus Sci Med. 2021 Aug;8(1). doi: 10.1136/lupus-2020-000444.
8
Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an Model.免疫刺激性内源性核酸使界面性皮炎持续存在——将致病基础转化为动物模型
Front Immunol. 2021 Jan 11;11:622511. doi: 10.3389/fimmu.2020.622511. eCollection 2020.
9
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.一种局部作用于 SYK 抑制剂治疗红斑狼疮的安全性、药代动力学和药效学:一项双盲 Ib 期研究。
Exp Dermatol. 2021 Nov;30(11):1686-1692. doi: 10.1111/exd.14253. Epub 2020 Dec 17.
10
Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.采用修订版 Wilson 和 Cleary 模型评估红斑狼疮患者生活质量的相关因素。
Lupus. 2020 Nov;29(13):1691-1703. doi: 10.1177/0961203320951842. Epub 2020 Sep 3.

本文引用的文献

1
A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.皮肤红斑狼疮患者报告结局的系统评价。
Br J Dermatol. 2017 Jan;176(1):52-61. doi: 10.1111/bjd.14868. Epub 2016 Dec 7.
2
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.西法莫单抗,一种抗干扰素-α单克隆抗体,用于中重度系统性红斑狼疮:一项随机、双盲、安慰剂对照研究。
Ann Rheum Dis. 2016 Nov;75(11):1909-1916. doi: 10.1136/annrheumdis-2015-208562. Epub 2016 Mar 23.
3
A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and dermatomyositis.一项关于皮肤红斑狼疮和皮肌炎中未治疗的抑郁和焦虑的横断面研究。
J Am Acad Dermatol. 2016 Feb;74(2):377-9. doi: 10.1016/j.jaad.2015.09.016.
4
Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study.静脉注射免疫球蛋白单药治疗皮肤型红斑狼疮患者的疗效:概念验证研究结果
Dermatol Reports. 2015 Mar 16;7(1):5804. doi: 10.4081/dr.2015.5804.
5
Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.美国以白人为主的人群中系统性红斑狼疮和皮肤性红斑狼疮的流行病学。
Arthritis Care Res (Hoboken). 2015 May;67(6):817-28. doi: 10.1002/acr.22502.
6
Cutaneous lupus erythematosus.皮肤型红斑狼疮
JAMA Dermatol. 2014 Mar;150(3):344. doi: 10.1001/jamadermatol.2013.10393.
7
Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.来那度胺治疗难治性皮肤红斑狼疮:一项52周试验的疗效与安全性
J Am Acad Dermatol. 2014 Mar;70(3):583-4. doi: 10.1016/j.jaad.2013.11.007.
8
Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan.评估日本皮肤病变红斑狼疮患者的生活质量。
Lupus. 2014;23(1):93-101. doi: 10.1177/0961203313509293. Epub 2013 Nov 6.
9
The impact of skin damage due to cutaneous lupus on quality of life.皮肤狼疮导致的皮肤损伤对生活质量的影响。
Br J Dermatol. 2014 Feb;170(2):315-21. doi: 10.1111/bjd.12653.
10
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.司库奇尤单抗治疗皮肤型或系统性红斑狼疮的I期随机、双盲、安慰剂对照、多次静脉注射、剂量递增研究
Arthritis Rheum. 2013 Oct;65(10):2661-71. doi: 10.1002/art.38091.